pembrolizumab
merck
['pembro', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)']
fantastic #gu23 review by on adjuvant therapy in #kidneycancer and why there have been such large apparent differences in various trials (only pembro positive so far). more is not always better put me in mind of this thread from a year ago: 
Professor of medicine | medical oncologist | head EH clinical school | Chair, ANZUP | husband, father, grandfather, blessed | want to make a positive difference